Product Information
LETROZOLE 2.5 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1535 per EA under NDC 62135049130. Its NADAC has been published 222 times since Mar 30, 2022.
Strength
2.5 mg/1
Manufacturer
Chartwell RX LLCNDC
62135049130
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LETROZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205869On Market Since
5/9/2019
Pharmacological Classes
Price Statistics
The NADAC for LETROZOLE 2.5 MG TABLET has been published 222 times since Mar 30, 2022, and over the history we have for it it has risen 14.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1535 per EA |
|---|---|
| All-time high | $0.1535 (Jun 24, 2026) |
| All-time low | $0.1009 (Jun 21, 2023) |
| 52-week high | $0.1535 |
| 52-week low | $0.1292 |
| Median price | $0.1358 |
| Average price | $0.1321 |
| Largest weekly change | +32.3% (Nov 22, 2023) |
| Weeks tracked | 222 |
| Tracking since | Mar 30, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LETROZOLE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LETROZOLE 2.5 MG TABLET, manufactured by Chartwell RX LLC, is $0.1535 per EA (NDC 62135049130), effective Jun 24, 2026.
How has the price of LETROZOLE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LETROZOLE 2.5 MG TABLET has risen 14.8%. It has been tracked across 222 weekly CMS publications since Mar 30, 2022.
What are the highest and lowest recorded NADAC prices for LETROZOLE 2.5 MG TABLET?
Since Mar 30, 2022, the NADAC for LETROZOLE 2.5 MG TABLET has ranged from a low of $0.1009 (Jun 21, 2023) to a high of $0.1535 (Jun 24, 2026), with a median of $0.1358 per EA.
Are there cheaper alternatives to LETROZOLE 2.5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LETROZOLE 2.5 MG TABLET, but none are currently priced below it.
Who manufactures LETROZOLE 2.5 MG TABLET?
LETROZOLE 2.5 MG TABLET (NDC 62135049130) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification